Publications by authors named "Graham Cooksley"

Claim this Profile
M
Molecular epidemiology of hepatitis B among Indigenous Australians in Queensland and the Torres Strait Islands.
Margaret Littlejohn, Lesley-Anne Jaskowski, Ros Edwards, Kathy Jackson, Lilly Yuen, Graham Cooksley

Intern Med J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detailed Polysomnography in Australian Vietnam Veterans With and Without Posttraumatic Stress Disorder.
Timothy Baird, Rebecca Theal, Sarah Gleeson, Sarah McLeay, Robyn O'Sullivan, Graham Cooksley

J Clin Sleep Med· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical comorbidities of post-traumatic stress disorder in Australian Vietnam War veterans.
Sarah C McLeay, Wendy M Harvey, Madeline Nm Romaniuk, Darrell Hg Crawford, David M Colquhoun, Graham Cooksley

Med J Aust· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.
Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, Henry Lik Yuen Chan, Rong-Nan Chien, Graham Cooksley

Hepatol Int· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.
Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, Henry Lik Yuen Chan, Rong-Nan Chien, Graham Cooksley

Hepatol Int· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin.
Mark G Swain, Ming-Yang Lai, Mitchell L Shiffman, W Graham E Cooksley, Stefan Zeuzem

Gastroenterology· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C.
Stuart K Roberts, Graham Cooksley, Gregory J Dore, Richard Robson, David Shaw

Hepatology· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B.
Michael W Fried, Teerha Piratvisuth, George K K Lau, Patrick Marcellin, Wan-Cheng Chow, Graham Cooksley

Hepatology· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine.
Pierre Vandepapelière, George K K Lau, Geert Leroux-Roels, Yves Horsmans, Edward Gane, Graham Cooksley

Vaccine· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users.
Yoann Morice, Jean-François Cantaloube, Stéphanie Beaucourt, Laetitia Barbotte, Sija De Gendt, Graham Cooksley

J Med Virol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection.
Carolyn A Lang, Sue Conrad, Lyndall Garrett, Diana Battistutta, W Graham E Cooksley

J Pain Symptom Manage· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic hepatitis B: a critical appraisal of current approaches to therapy.
Robert P Perrillo, Robert G Gish, Marion Peters, Emmet B Keeffe, Alfredo Alberti, W Graham E Cooksley

Clin Gastroenterol Hepatol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginterferon-alpha 2a for the treatment of hepatitis B infection.
W Graham E Cooksley

Expert Opin Pharmacother· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
George K K Lau, Teerha Piratvisuth, Kang Xian Luo, Patrick Marcellin, Satawat Thongsawat, Graham Cooksley

N Engl J Med· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapies for viral hepatitis workshop. 2-3 November 2004, Boston, MA, USA.
Graham Cooksley

IDrugs· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B vaccine boosters: is there a clinical need in high endemicity populations?
T Jacob John, Graham Cooksley,

J Gastroenterol Hepatol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?
Graham Cooksley

Nat Clin Pract Gastroenterol Hepatol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with interferons (including pegylated interferons) in patients with hepatitis B.
W Graham Cooksley

Semin Liver Dis· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C.
S D Sullivan, D M Jensen, D E Bernstein, T I Hassanein, G R Foster, Graham Cooksley

Am J Gastroenterol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region.
Mohammed S Jazayeri, Ashraf A Basuni, Graham Cooksley, Stephen Locarnini, William F Carman

J Hepatol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of hepatitis B with interferon and combination therapy.
W Graham Cooksley

Clin Liver Dis· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.
Tarek Hassanein, Graham Cooksley, Mark Sulkowski, Coleman Smith, George Marinos

J Hepatol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance and benefits of hepatitis A prevention in chronic liver disease patients.
Graham Cooksley

J Gastroenterol Hepatol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of interferon therapy in hepatitis B.
W Graham E Cooksley

MedGenMed· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The treatment of hepatitis B e antigen-positive chronic hepatitis B with pegylated interferon.
Graham Cooksley

J Hepatol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis